Ben Ho Park (Brad A Davidson, Ben H Park)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Estrogen Receptor

Electronic Health Record

Metastatic Breast Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Communications biology

JCO clinical cancer informatics

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Brad A Davidson, Adam X Miranda, Sarah C Reed, Riley E Bergman, Justin D J Kemp, Anvith P Reddy, Morgan V Pantone, Ethan K Fox, R Dixon Dorand, Paula J Hurley, Sarah Croessmann, Ben Ho Park
An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release. Communications biology 7 (1) (2024)
Brad A Davidson, Adam X Miranda, Sarah C Reed, Riley E Bergman, Justin D J Kemp, Anvith P Reddy, Morgan V Pantone, Ethan K Fox, R Dixon Dorand, Paula J Hurley, Sarah Croessmann, Ben Ho Park
An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release. Communications biology 7 (1) (2024)
Levente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, Michele L LeNoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha M Jain, Marilyn E Holt, Christina N Maxwell, Madeleine Ball, Yufang Ma, Margaret B Mitchell, Douglas B Johnson, David S Smith, Ben Ho Park, Christine M Micheel, Daniel Fabbri, Jan Wolber, Travis J Osterman
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO clinical cancer informatics 8 (2024)
Brad A Davidson, Adam X Miranda, Sarah C Reed, Riley E Bergman, Justin D J Kemp, Anvith P Reddy, Morgan V Pantone, Ethan K Fox, R Dixon Dorand, Paula J Hurley, Sarah Croessmann, Ben Ho Park
An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release. Communications biology 7 (1) (2024)
Levente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, Michele L LeNoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha M Jain, Marilyn E Holt, Christina N Maxwell, Madeleine Ball, Yufang Ma, Margaret B Mitchell, Douglas B Johnson, David S Smith, Ben Ho Park, Christine M Micheel, Daniel Fabbri, Jan Wolber, Travis J Osterman
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO clinical cancer informatics 8 (2024)
Brad A Davidson, Adam X Miranda, Sarah C Reed, Riley E Bergman, Justin D J Kemp, Anvith P Reddy, Morgan V Pantone, Ethan K Fox, R Dixon Dorand, Paula J Hurley, Sarah Croessmann, Ben Ho Park
An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release. Communications biology 7 (1) (2024)
Levente Lippenszky, Kathleen F Mittendorf, Zoltán Kiss, Michele L LeNoue-Newton, Pablo Napan-Molina, Protiva Rahman, Cheng Ye, Balázs Laczi, Eszter Csernai, Neha M Jain, Marilyn E Holt, Christina N Maxwell, Madeleine Ball, Yufang Ma, Margaret B Mitchell, Douglas B Johnson, David S Smith, Ben Ho Park, Christine M Micheel, Daniel Fabbri, Jan Wolber, Travis J Osterman
Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data. JCO clinical cancer informatics 8 (2024)
Santanu Ghosh, Rachel Yang, Darjan Duraki, Junyao Zhu, Ji Eun Kim, Musarrat Jabeen, Chengjian Mao, Xinyi Dai, Mara R Livezey, Matthew W Boudreau, Ben Ho Park, Erik Russell Nelson, Paul J Hergenrother, David J Shapiro
Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy-Induced Necrosis. Cancer research (2023)
Norah L Henry, Mark R Somerfield, Zoneddy Dayao, Anthony D Elias, Kevin Kalinsky, Lisa Meier McShane, Beverly Moy, Ben Ho Park, Kelly M Shanahan, Priyanka Sharma, Rebecca Shatsky, Erica M Stringer-Reasor, Melinda Telli, Nicholas C Turner, Angela M DeMichele
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Kristin A Altwegg, Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu, Junhao Liu, Uday P Pratap, Behnam Ebrahimi, John R Sanchez, Xiaonan Li, Shihong Ma, Ben Ho Park, Bindu Santhamma, Yidong Chen, Zhao Lai, Ganesh V Raj, Yaxia Yuan, Daohong Zhou, Gangadhara R Sareddy, Rajeshwar R Tekmal, Stanton F McHardy, Tim Hui-Ming Huang, Manjeet K Rao, Hariprasad Vankayalapati, Ratna K Vadlamudi
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer. Cancer research 82 (20) (2022)
Sarah C Reed, Sarah Croessmann, Ben Ho Park
CHIP Happens: Clonal hematopoiesis of indeterminate potential and its relationship to solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jessica A Lavery, Eva M Lepisto, Samantha Brown, Hira Rizvi, Caroline McCarthy, Michele LeNoue-Newton, Celeste Yu, Jasme Lee, Xindi Guo, Thomas V Yu, Julia Rudolph, Shawn Sweeney, null null, Ben Ho Park, Jeremy L Warner, Philippe L Bedard, Gregory J Riely, Deborah Schrag, Katherine S Panageas
A Scalable Quality Assurance Process for Curating Oncology Electronic Health Records: The Project GENIE Biopharma Collaborative Approach. JCO clinical cancer informatics 6 (2022)
Minetta C Liu, Matthew MacKay, Matthew Kase, Aneta Piwowarczyk, Christine Lo, Jeff Schaeffer, Justin D Finkle, Christopher E Mason, Nike Beaubier, Kimberly L Blackwell, Ben Ho Park
Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer. JCO precision oncology 6 (1) (2022)
Ben Ho Park, Sarah Croessmann, Ben H Park
The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer. British journal of cancer 125 (6) (2021)
Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, William Fraser Symmans, Ben Ho Park, Brian L Burnette, Amye J Tevaarwerk, Sofia F Garcia, Karen Lisa Smith, Della F Makower, Margaret Block, Kimberly A Morley, Chirag R Jani, Craig Mescher, Shabana J Dewani, Bernard Tawfik, Lisa E Flaum, Erica L Mayer, William M Sikov, Eve T Rodler, Lynne I Wagner, Angela M DeMichele, Joseph A Sparano, Antonio C Wolff, Kathy D Miller
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Ingrid A Mayer, Fengmin Zhao, Carlos L Arteaga, William Fraser Symmans, Ben Ho Park, Brian L Burnette, Amye J Tevaarwerk, Sofia F Garcia, Karen Lisa Smith, Della F Makower, Margaret Block, Kimberly A Morley, Chirag R Jani, Craig Mescher, Shabana J Dewani, Bernard Tawfik, Lisa E Flaum, Erica L Mayer, William M Sikov, Eve T Rodler, Lynne I Wagner, Angela M DeMichele, Joseph A Sparano, Antonio C Wolff, Kathy D Miller
Reply to T. Shimoi et al and Y. Shimanuki et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Caitriona Cahir, Jeffrey P Leal, Lilja Solnes, Chiung-Yu Huang, Ashley Carpenter, Katy Gaffney, Vandana G Abramson, Lisa Anne Carey, Minetta C Liu, Mothaffar F Rimawi, Jennifer M Specht, Anna Maria V Storniolo, Vicente Valero, Christos Vaklavas, Ian E Krop, Eric P Winer, Melissa Camp, Robert S Miller, Antonio C Wolff, Ashley Cimino-Mathews, Ben Ho Park, Richard L Wahl, Vered Stearns
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (20) (2021)
Kelly Kyker-Snowman, Robert M Hughes, Christopher L Yankaskas, Karen Cravero, Swathi Karthikeyan, Berry Button, Ian Waters, David Marc Rosen, Lauren Dennison, Natasha Hunter, Josh Donaldson, Eric S Christenson, Konstantinos Konstantopoulos, Paula J Hurley, Sarah Croessmann, Ben Ho Park
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties. Breast cancer research and treatment 179 (3) (2019)
Berry Button, Sarah Croessmann, David Chu, D Marc Rosen, Daniel J Zabransky, W Brian Dalton, Karen Cravero, Kelly Kyker-Snowman, Ian Waters, Swathi Karthikeyan, Eric S Christenson, Josh Donaldson, Tasha Hunter, Lauren Dennison, Cody Ramin, Betty May, Richard Roden, Dana Petry, Deborah K Armstrong, Kala Visvanathan, Ben Ho Park
The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies. Breast cancer research and treatment 174 (2) (2018)
Kelly Kyker-Snowman, Bracha Erlanger Avigdor, Mansoor Nasim, Ashley Cimino-Mathews, Sarah J Wheelan, Pedram Argani, Ben Ho Park
A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing. Breast cancer research and treatment 170 (2) (2018)